ROS-Targeted Nanoprobes for Detection and Imaging of Cellular Senescence

Principal Investigator: 

Ching-Hsuan Tung

Background & Unmet Need

  • Cellular senescence is a state of irreversible cell cycle arrest associated with aging, in which cells stop proliferating
  • Senescent cells are drug resistant and may secrete factors such as cytokines into surrounding tissues, causing low-grade inflammation
  • Senescence can be caused by cellular stress or damage, including mitochondrial dysfunction, oxidative stress, or DNA damage
  • Cells can also become senescent in response to chemotherapy and escape treatment, leading to future tumor recurrence
  • Senescence is currently imaged using beta-galactosidase (Xgal); however, this label is not senescence-specific and requires cell fixing and long incubation times
  • Unmet Need: Improved methods for detection and imaging of senescent cells

Technology Overview

  • The Technology: A novel fluorogenic nanoprobe for labeling cellular senescence via detection of reactive oxygen species (ROS)
  • ROS are known to play a role in progression and maintenance of cell senescence, and ROS levels are directly related to induction of cellular senescence
  • The inventors have created a novel nanoprobe, D3, which fluoresces in response to high levels of ROS, thereby labeling senescent cells
  • PoC Data: In tumor-bearing mice, D3 accumulated quickly and preferentially in tumors when administered intravenously
  • Fluorescent signal from D3 was specifically turned on in senescent tumors, which were induced via treatment of tumor-bearing mice with Palbociclib
  • The fluorescence signal from D3 in senescent tumors was 3-fold higher than that of non-senescent tumors

Technology Applications

  • Imaging nanoprobe to identify senescent tumors following chemotherapy
  • Long-term study of disease progression and treatment response for senescence-associated conditions, including aging and fibrosis
  • Real-time imaging of changes in cellular senescence
  • Identification and isolation of senescent cells for further research

Technology Advantages

  • D3 is remarkably stable in normal physiological conditions
  • D3 does not require cells to be fixed or to undergo long incubation times
  • Fluorescence intensity of D3 is dependent on ROS production level and corresponds to senescence progression, allowing for real-time imaging
D3 detects palbociclib-induced senescence in vitro.

Figure 1: D3 detects palbociclib-induced senescence in vitro

Intellectual Property

Patents

  • Provisional Application Filed

Cornell Reference

  • 10582

Contact Information

Louise Sarup, Ph.D

For additional information please contact

Louise Sarup
Associate Director, Business Development and Licensing
Phone: (646) 962-3523
Email: lss248@cornell.edu